 SAN DIEGO, May 12, 2021 GLOBE NEWSWIRE -- Adamis Pharmaceuticals Corporation NASDAQ: ADMP, a biopharmaceutical company developing and commercializing specialty products for respiratory disease, allergy and opioid overdose, today announced that it will host an investor conference call on Monday, May 17, 2021 at 2 p.m. Pacific Time to discuss its financial and operating results for the first quarter of 2021 as well as provide a business update. The companys press release concerning its first quarter 2021 financial results will be available after 1 p.m. Pacific Time on May 17, 2021 and on its website at and the company also expects to file its quarterly report on Form 10-Q for the quarter ended March 31, 2021 on that date. 